Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
Cancer Treatment Reports
|
June 1, 1985
Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin
J J Fiore, D P Kelsen, R J Gralla, et al.
Cancer
|
February 19, 1999
Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma
K G Billingsley, J J Lewis, D H Leung, et al.
Cancer
|
January 1, 1994
The effect of age at diagnosis on outcome in rhabdomyosarcoma
M P La Quaglia, G Heller, F Ghavimi, et al.
Cancer Clinical Trials
|
January 1, 1981
Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma
G R Lynch, R J Gralla, D P Kelsen, et al.
Cancer
|
November 26, 1999
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
F Fata, E O'Reilly, D Ilson, et al.
Cancer
|
September 15, 1991
A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors
E S Casper, J J Gaynor, S I Hajdu, et al.
Annals of Surgical Oncology
|
May 1, 1994
Effect of perioperative blood transfusion on recurrence and survival in 232 primary high-grade extremity sarcoma patients
M J Heslin, J J Gaynor, E Newman, et al.
Breast Cancer Research and Treatment
|
January 1, 1987
Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin
E S Casper, C A Guidera, G J Bosl, et al.
Cancer Treatment Reports
|
June 1, 1983
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer
L A Kalman, M G Kris, R J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management
M J Heslin, J J Lewis, E Nadler, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
Cancer Treatment Reports
|
June 1, 1985
Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin
J J Fiore, D P Kelsen, R J Gralla, et al.
Cancer
|
February 19, 1999
Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma
K G Billingsley, J J Lewis, D H Leung, et al.
Cancer
|
January 1, 1994
The effect of age at diagnosis on outcome in rhabdomyosarcoma
M P La Quaglia, G Heller, F Ghavimi, et al.
Cancer Clinical Trials
|
January 1, 1981
Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma
G R Lynch, R J Gralla, D P Kelsen, et al.
Cancer
|
November 26, 1999
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
F Fata, E O'Reilly, D Ilson, et al.
Cancer
|
September 15, 1991
A prospective randomized trial of adjuvant chemotherapy with bolus versus continuous infusion of doxorubicin in patients with high-grade extremity soft tissue sarcoma and an analysis of prognostic factors
E S Casper, J J Gaynor, S I Hajdu, et al.
Annals of Surgical Oncology
|
May 1, 1994
Effect of perioperative blood transfusion on recurrence and survival in 232 primary high-grade extremity sarcoma patients
M J Heslin, J J Gaynor, E Newman, et al.
Breast Cancer Research and Treatment
|
January 1, 1987
Combined modality treatment of locally advanced breast cancer: adjuvant combination chemotherapy with and without doxorubicin
E S Casper, C A Guidera, G J Bosl, et al.
Cancer Treatment Reports
|
June 1, 1983
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer
L A Kalman, M G Kris, R J Gralla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1997
Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management
M J Heslin, J J Lewis, E Nadler, et al.
Page
of 11